Governance

Clinical Trials Ontario is an independent not-for-profit organization established with support from the Ontario Government. We have strong governance from an effective Board of Directors dedicated to advancing patient care while serving the interests of government, industry, clinicians, patients and other stakeholders.

Board of Directors

CTO is proud to have a committed Board of Directors with diverse experiences in the life sciences sector.

Raphael Hofstein Chair Former President and Chief Executive Officer of Toronto Innovation Acceleration Partners (TIAP)	Dr. Bradly Wouters Vice-Chair and Secretary Executive VP, Science & Research University Health Network	Bev Heim-Myers Treasurer Chair Canadian Coalition for Genetic Fairness
Tina Ceroni Clinical Trial Participant	Anne Ellis Associate Professor and Chair, Division of Allergy & Immunology, Department of Medicine, Queen’s University	James Wilson President Brancorth Medical Inc.
Kym Boycott Clinician Scientist, CHEO Research Institute; Professor of Pediatrics, University of Ottawa; Tier 1 Canada Research Chair in Rare Disease Precision Health	Mark Lundie, PhD Vice President & Global Medical Lead, Rare Endocrinology and Neurology, Pfizer Inc	Clive Ward-Able President, Clintell Inc.